Gene editing holds potential for addressing Alzheimer's disease, particularly through early detection and intervention strategies. Research indicates that genetic markers, such as the APOE gene, influence the risk of developing Alzheimer's, with specific alleles potentially lowering this risk. While gene editing in embryos could theoretically reduce Alzheimer's prevalence, the practicality and ethical implications of such interventions remain contentious. Current discussions emphasize the importance of understanding genetic interactions and the complexities of late-onset Alzheimer's, as well as the challenges in developing effective treatments. Overall, while gene editing may contribute to future Alzheimer's therapies, significant research and ethical considerations are still needed.